LAVA-039

N/A

Report date: 2023/01/04 11:26:53

Base Information

Drug NameLAVA-039
Drug Alias NameLAVA-039LAVA039
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-CD1dAnti-TRGV9
TargetsCD1d antigensT cell receptor gamma variable 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVu University Medical CenterLava Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesLava Therapeutics NV
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A